8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Sep 14, 2009)

Filed September 14, 2009For Securities:ELV

Summary

This Form 8-K filing by WellPoint, Inc. (now Elevance Health, Inc.) on September 14, 2009, primarily serves to inform the market about upcoming communications with securities analysts and investors. During the period of September 14-25, 2009, company officers were expected to reaffirm WellPoint's full-year 2009 earnings per share (EPS) guidance. This guidance was initially provided on July 29, 2009, through a press release and conference call. The filing also includes a standard Safe Harbor statement, outlining the forward-looking nature of certain statements and the risks and uncertainties that could impact actual results. For investors, the key takeaway is the reaffirmation of existing earnings guidance, suggesting management's confidence in meeting previously stated financial targets for the year. The filing itself does not introduce new financial results or significant strategic changes, but rather reiterates prior guidance. Investors should note that the forward-looking statements are subject to various risks, including regulatory changes, healthcare cost trends, and competitive pressures, as detailed in the company's broader SEC filings.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) filed an 8-K on September 14, 2009.
  • 2Company officers were scheduled to speak with analysts and investors from September 14-25, 2009.
  • 3During these meetings, WellPoint expected to reaffirm its full-year 2009 earnings per share (EPS) guidance.
  • 4The 2009 EPS guidance had been previously issued on July 29, 2009.
  • 5The filing includes a Safe Harbor statement for forward-looking statements.
  • 6The report emphasizes that information provided is for disclosure purposes and not considered 'filed' for Section 18 purposes.
  • 7The company's principal executive offices are located in Indianapolis, IN.

Frequently Asked Questions

The main purpose of this 8-K filing is to notify the market that WellPoint's officers would be meeting with securities analysts and investors between September 14 and September 25, 2009, to reaffirm the company's previously issued earnings per share (EPS) guidance for the full year 2009.

No, this filing did not release new financial results or guidance. It served as a communication tool to reaffirm the company's existing full-year 2009 EPS guidance, which was initially provided on July 29, 2009.

The filing mentions several risks and uncertainties that could affect forward-looking statements, including government participation and regulation in health benefits, trends in healthcare costs and utilization, premium rate increases, provider contracting, competitor pricing, enrollment changes, risks related to Medicare Part C and D programs, financial strength ratings, litigation, share repurchase expectations, impacts from the Express Scripts transaction, and general economic conditions.

The filing explicitly states that the information furnished in this report shall not be deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be incorporated by reference into any future filings under the Securities Act of 1933, unless specifically stated otherwise.